Menu
Israeli President Reuven Rivlin's message to global Jewry amid coronavirus crisis

Israeli President Reuven Rivlin's m…

Israeli President Reuven ...

PM Netanyahu orders establishment of national command center for Coronavirus medical procurement

PM Netanyahu orders establishment o…

The national command cent...

President Rivlin addresses the Bundestag

President Rivlin addresses the Bund…

President Rivlin: The thr...

PM Netanyahu meets with doctors from the Arab sector

PM Netanyahu meets with doctors fro…

This is an epidemic that ...

PM Netanyahu holds conference call with European leaders

PM Netanyahu holds conference call …

We can help our countries...

Prev Next
A+ A A-
Booking.com

Israel Innovation Authority will launch the second biotech incubator Featured

In light of the success of FutuRX incubator, and following the Israeli government's decision, IIA will launch the second biotech incubator in northern Israel.

After the Israel Innovation Authority ’s technological start-up incubators have proven themselves as an important tool for creating innovative companies in a variety of fields, this week the Authority announced its intention to launch a new competitive tender to open its second biotech incubator.
This additional biotech incubator will serve as a gateway for multinational pharmaceutical companies and specialist investment funds to support Israeli start-ups. The goal of the biotech incubator is to help build the pharmaceutical industry in Israel by connecting investors and strategic partners who can help identify innovative technological projects and help transform them into new companies.
"In Israel’s northern region, research infrastructure, relevant services and a vast potential of human capital are emerging. These basic assets – together with a biotech incubator that will help establish new startups –will make it possible to create an important ecosystem in the field and to strengthen the pharmaceutical industry in Israel", noted Israel Innovation Authority’s CEO, Aharon Aharon.

FutuRx: The first biotech incubator in Israel
The first tender brought two multinational corporations to Israel: Johnson & Johnson from the US and Takeda from Japan, together with the long-established venture capital fund OrbiMed. The FutuRx incubator , located in the city of Rehovot, has already invested in establishing 10 startups, and the complementary capabilities of multinational corporations along with a venture capital fund have already proven to bring great value to startups – both within the incubator and after the companies leave.
"We attribute great importance to understanding the needs of the hi-tech industry, adapting programs to these needs, and developing technology”, added Israel’s Minister of Economy and Industry, Eli Cohen. “Our job is first and foremost to serve the industry and enable it to develop and receive the optimal support needed to succeed. This is another part of the ongoing ‘Northern Plan’".
Last modified onWednesday, 25 March 2020 13:41

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top

Sections

Jewish Traditions

About Us

Community

Cooperations

Follow Us